Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
lenalidomide (revlimid) (1 trial)
Complex Regional Pain Syndromes (Phase 3)
Reflex Sympathetic Dystrophy (Phase 3)
Somatoform Disorders (Phase 3)
Syndrome (Phase 3)
Trials (1 total)
Trial APIs (1 total)